Zions Bancorporation’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-43
Closed -$1.78K 918
2023
Q1
$1.78K Sell
43
-13,664
-100% -$585K ﹤0.01% 828
2022
Q4
$565K Sell
13,707
-382
-3% -$15.5K 0.04% 233
2022
Q3
$617K Sell
14,089
-5
-0% -$242 0.06% 204
2022
Q2
$693K Buy
14,094
+2,700
+24% +$145K 0.07% 205
2022
Q1
$646K Buy
11,394
+3,033
+36% +$161K 0.06% 215
2021
Q4
$439K Buy
8,361
+1,312
+19% +$71.3K 0.04% 240
2021
Q3
$422K Buy
7,049
+719
+11% +$44.3K 0.04% 222
2021
Q2
$429K Buy
6,330
+852
+16% +$58.2K 0.04% 191
2021
Q1
$359K Buy
5,478
+1,195
+28% +$71.7K 0.04% 191
2020
Q4
$241K Buy
4,283
+190
+5% +$9.35K 0.03% 232
2020
Q3
$199K Buy
4,093
+266
+7% +$14.3K 0.03% 226
2020
Q2
$213K Buy
3,827
+340
+10% +$19.7K 0.03% 208
2020
Q1
$177K Buy
3,487
+850
+32% +$57K 0.03% 198
2019
Q4
$204K Sell
2,637
-662
-20% -$46.7K 0.03% 220
2019
Q3
$209K Buy
3,299
+19
+0.6% +$1.19K 0.03% 238
2019
Q2
$192K Buy
3,280
+190
+6% +$11.2K 0.03% 237
2019
Q1
$175K Buy
+3,090
New +$164K 0.03% 241
2018
Q4
Sell
-3,176
Closed -$225K 794
2018
Q3
$225K Buy
+3,176
New +$202K 0.05% 160
2017
Q4
Sell
-2,885
Closed -$160K 1006
2017
Q3
$160K Buy
+2,885
New +$191K 0.02% 310

Other funds holding NUVA

Zions Bancorporation's NUVA Position: Q2 2023 in Review

Zions Bancorporation sold out of NuVasive, Inc. (NUVA) in Q2 2023, closing a stake of 43 shares — an estimated $1.78K sold.

Zions Bancorporation first reported a position in NUVA in Q3 2017 and held it in 19 quarters. The position peaked at $693K in Q2 2022. 228 funds tracked by Wall St. Rank hold NUVA as of Q2 2023.

  • Zions Bancorporation reported no remaining NuVasive, Inc. position as of Q2 2023 after selling out during the quarter.
  • Zions Bancorporation sold 43 NuVasive, Inc. shares in Q2 2023, an estimated $1.78K.
  • Zions Bancorporation first reported a position in NuVasive, Inc. in Q3 2017 and held it in 19 quarters.
  • Zions Bancorporation's NuVasive, Inc. position peaked at $693K in Q2 2022.
  • 228 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2023.

Based on Zions Bancorporation's 13F filing for Q2 2023, filed 28 Jul 2023.